Department of Medicine

speed bump sign
July 5, 2016

New NIH-funded center to study inefficiencies in clinical trials

Researchers at Vanderbilt University Medical Center and Duke Clinical Research Institute have received a major federal grant to study how multisite clinical trials of new drugs and therapies in children and adults can be conducted more rapidly and efficiently.

By Bill Snyder
pair of tango dancers outdoors
June 23, 2016

It takes two to tango: beta cell development

Defining the genes required for the function of insulin-producing beta cells is crucial for ongoing efforts to develop a cell-based therapy for diabetes.

By Bill Snyder
June 22, 2016

Lovly tapped to brief Congress on cancer research

Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology, has been selected to testify before members of Congress about the importance of cancer research, including early training programs for individuals interested in science.

By Doug Campbell
molecules stuck together
June 2, 2016

‘Young Scientist’ showcases high schoolers’ research at Vanderbilt

High school students performing advanced research at Vanderbilt have the opportunity to share their findings with the scientific community through a journal of their own.

By VUMC News and Communications
May 26, 2016

Family’s diabetes experiences propel Tour de Cure participation

When the Mullis family straps on their helmets on June 11 to ride in the local Tour de Cure, one of a series of cycling events held nationally to benefit the American Diabetes Association (ADA), they will remember a day seven years ago that motivated their annual participation in the event.

By Jill Clendening
May 26, 2016

Precision medicine already changing cancer treatment strategies

The ability to test patients’ cancers for individual differences, mainly at the genetic level, and to make treatment decisions based on those differences is the hallmark of precision medicine, and Vanderbilt University Medical Center (VUMC) is among the leaders of this new approach to diagnosis and treatment.

By VUMC News and Communications
May 19, 2016

Williams to lead physician-scientist training program 

Christopher Williams, M.D., Ph.D., associate professor of Medicine and Cancer Biology, was recently named associate dean for Vanderbilt University School of Medicine’s Physician-Scientist Education and Training Program (PSTP) and director of the Medical Science Training Program (MSTP).
By Jessica Pasley
May 12, 2016

Medical societies honor four VUMC physicians

Four physicians from Vanderbilt University Medical Center (VUMC) have been elected to membership in two of the nation’s oldest and most respected medical honor societies — the Association of American Physicians (AAP) and the American Society for Clinical Investigation (ASCI).
By Bill Snyder
May 5, 2016

Gannon to chair ADA science session planning committee

Maureen Gannon, Ph.D., associate professor of Medicine, has been appointed chair of the American Diabetes Association (ADA) Scientific Session planning committee.
By Bill Snyder
April 28, 2016

Study links COPD with increased bacterial invasion

Chronic obstructive pulmonary disease (COPD) is a common smoking-related lung illness and the third leading cause of death in the United States. Scientists have long believed that inhaling toxic gases and particles from tobacco smoke causes inflammation of the small airways in the lungs, leading to the development of COPD.
By VUMC News and Communications
April 21, 2016

Study explores how some breast cancers resist treatment

A targeted therapy for triple-negative breast cancer (TNBC), the most aggressive form of breast cancer, has shown potential promise in a recently published study. TNBC is the only type of breast cancer for which there are no currently approved targeted therapies.
By VUMC News and Communications
April 21, 2016

May 4 symposium to highlight heart-related basic, clinical research

The Division of Cardiovascular Medicine will host the Vanderbilt Cardiovascular Symposium 2016 on May 4, highlighting ongoing vascular and heart-related basic and clinical research.
By Kathy Whitney
April 14, 2016

First subject enrolled in international HIV prevention study

This month an international HIV prevention trial was launched that is testing the infection-preventing prowess of a monoclonal antibody called VRCO1.
By Paul Govern